Your browser doesn't support javascript.
loading
The Efficacy of Corticosteroid Therapy in a Patient with Non-alcoholic Steatohepatitis Overlapping Autoimmune Hepatitis.
Komura, Takuya; Ohta, Hajime; Seike, Takuya; Shimizu, Yoshiaki; Nakai, Ryotaro; Omura, Hitoshi; Kagaya, Takashi; Kasashima, Satomi; Kawashima, Atsuhiro; Oba, Sakae; Harada, Kennichi; Kaneko, Shuichi; Unoura, Masashi.
Afiliação
  • Komura T; Department of Gastroenterology, National Hospital Organization Kanazawa Medical Center, Japan.
  • Ohta H; System Biology, Graduate School of Advanced Preventive Medical Sciences, Kanazawa University, Japan.
  • Seike T; Department of Gastroenterology, National Hospital Organization Kanazawa Medical Center, Japan.
  • Shimizu Y; Department of Gastroenterology, National Hospital Organization Kanazawa Medical Center, Japan.
  • Nakai R; Department of Gastroenterology, National Hospital Organization Kanazawa Medical Center, Japan.
  • Omura H; Department of Gastroenterology, National Hospital Organization Kanazawa Medical Center, Japan.
  • Kagaya T; Department of Gastroenterology, National Hospital Organization Kanazawa Medical Center, Japan.
  • Kasashima S; Department of Gastroenterology, National Hospital Organization Kanazawa Medical Center, Japan.
  • Kawashima A; Department of Clinical Laboratory, National Hospital Organization Kanazawa Medical Center, Japan.
  • Oba S; Department of Clinical Laboratory, National Hospital Organization Kanazawa Medical Center, Japan.
  • Harada K; Sakae Internal Medical Clinic, Japan.
  • Kaneko S; Department of Human Pathology, Kanazawa University Graduate School of Medical Sciences, Japan.
  • Unoura M; System Biology, Graduate School of Advanced Preventive Medical Sciences, Kanazawa University, Japan.
Intern Med ; 57(6): 807-812, 2018 Mar 15.
Article em En | MEDLINE | ID: mdl-29151501
ABSTRACT
The overlap of multiple liver diseases can cause the disease activity and severity to worsen rapidly in some cases. We rarely see patients with non-alcoholic steatohepatitis (NASH) with overlapping autoimmune hepatitis (AIH). A 64-year-old woman who had been prescribed oral drugs to treat diabetes and hypertension (metformin 500 mg/day and voglibose 0.9 mg/day, and termisartan 40 mg/day and amlodipine 5 mg/day, respectively) was diagnosed with NASH with histological confirmation. At 68 years of age, her liver injury worsened with an IgG of 2,871 mg/dL and a high serum anti-nuclear antibody (ANA) level of 2,560. We repeated the liver biopsy, which revealed NASH and mild interface hepatitis with some lobular focal necrosis consisting of overlapping AIH. Therefore, she was treated with 30 mg of prednisolone daily. The treatment led to an improvement in her IgG levels and ANA in the serum and an improvement in the histology results.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Prednisolona / Hepatite Autoimune / Hepatopatia Gordurosa não Alcoólica / Cirrose Hepática Biliar / Anti-Inflamatórios Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Prednisolona / Hepatite Autoimune / Hepatopatia Gordurosa não Alcoólica / Cirrose Hepática Biliar / Anti-Inflamatórios Idioma: En Ano de publicação: 2018 Tipo de documento: Article